General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
By far, the fastest growing segment over the forecast period is represented by microfracture adjunct market. The procedure is complementary to microfracture which provides a very large market for implant sales to penetrate. No other segment is expected to grow as strongly.
Microfracture procedures are the standard to which new products and procedures are compared. Their positive results and low cost creates barriers for new product entry, as new products and procedures on the market must surpass microfracture procedures in terms of cost or efficacy.
Surgeons repairing cartilage damage are no doubt awaiting new technological developments which may likely involve stem cell products offered at more competitive prices. However, an implant that will truly impact the market by providing clinically backed, long-term cartilage repair at low cost remains years away.
'
TABLE OF CONTENTS I
LIST OF FIGURES XVIII
LIST OF CHARTS XX
EXECUTIVE SUMMARY 1
U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.1.1 Osteology and Musculoskeletal System 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 General Diagnostic 28
2.2.2 Osteoporosis 29
2.2.3 Osteoarthritis 29
2.2.4 Indication for Bone Graft Procedure 30
2.2.5 Indication for Cartilage Repair 31
2.2.6 Degenerative Disc Disease 32
2.3 PATIENT DEMOGRAPHICS 34
2.3.1 General Statistics 34
PRODUCT ASSESSMENT 36
3.1 PRODUCT PORTFOLIOS 36
3.1.1 Cartilage Repair 37
3.2 REGULATORY ISSUES AND RECALLS 39
3.2.1 Cartilage Repair 39
3.3 CLINICAL TRIALS 40
3.3.1 Cartilage Repair 40
ORTHOPEDIC CARTILAGE REPAIR MARKET 45
4.1 INTRODUCTION 45
4.1.1 Anatomy 45
4.1.2 Methods for Cartilage Repair 45
4.1.2.1 Microfracture 45
4.1.2.2 Microfracture Adjunct 46
4.1.2.3 Osteoarticular Autograft Transfer System 46
4.1.2.4 Particulated Juvenile Allograft 46
4.1.2.5 Osteochondral Allograft Transfer 46
4.1.2.6 Autologous Chondrocyte Implantation 47
4.1.2.7 Meniscal Allograft Transplantation 47
4.2 MARKET OVERVIEW 48
4.3 MARKET ANALYSIS AND FORECAST 52
4.3.1 Osteochondral Allograft Market 52
4.3.2 Meniscal Allograft Market 54
4.3.3 Autologous Chondrocyte Implantation Market 56
4.3.4 Particulated Juvenile Allograft Implant Market 58
4.3.5 Microfracture Adjunct Market 60
4.4 DRIVERS AND LIMITERS 62
4.4.1 Market Drivers 62
4.4.2 Market Limiters 62
4.5 COMPETITIVE MARKET SHARE ANALYSIS 64
ABBREVIATIONS 68
APPENDIX II: COMPANY PRESS RELEASES 70
Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023 3
Chart 4 1: Orthopedic Cartilage Repair Market by Segment, U.S., 2013 – 2023 50
Chart 4 2: Orthopedic Cartilage Repair Market Breakdown, U.S., 2016 51
Chart 4 3: Orthopedic Cartilage Repair Market Breakdown, U.S., 2023 51
Chart 4 4: Osteochondral Allograft Market, U.S., 2013 – 2023 53
Chart 4 5: Meniscal Allograft Market, U.S., 2013 – 2023 55
Chart 4 6: Autologous Chondrocyte Implantation Market, U.S., 2013 – 2023 57
Chart 4 7: Particulated Juvenile Allograft Implant Market, U.S., 2013 – 2023 59
Chart 4 8: Microfracture Adjunct Market, U.S., 2013 – 2023 61
Chart 4 9: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2016 67
MedtronicGenzymeDePuy SynthesAnika TherapeuticsFerring PharmaceuticalsStrykerNuVasiveBioventusZimmer BiometIntegra LifeSciencesRTI SurgicalFidia PharmaceuticalsMTFOrthofixArthrexAlloSourceAastromBaxterHarvest TechnologiesWright MedicalBacterin InternationalArteriocyteExactechLifeNet HealthBiocompositesAlphatec SpineCelling BiosciencesGlobus MedicalNuo TherapeuticsK2M*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.